ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신경유전학적 검사 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 12.7%의 연평균 성장률(CAGR)로 11억 2,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료의 적용 확대, 만성질환의 증가, 병원 수 증가, 진단 실험실 수 증가, 질병 조기 발견에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 비침습적 검사법 채택 확대, 신제품 개발, 전략적 제휴, 신경질환의 새로운 바이오마커 등장 등이 있습니다.
향후 5년간 12.7%의 성장률 전망은 지난번 전망치보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 한국이나 핀란드에서 수입되는 전장유전체 시퀀싱 키트와 인공지능 기반 변종 해석 소프트웨어의 비용을 상승시키고, 진단을 지연시키거나 신경유전학 연구소의 운영비용을 상승시킬 수 있기 때문에 미국의 정밀신경학에 혼란을 초래할 수 있습니다. 혼란을 야기할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
신경질환의 증가는 신경유전학 검사 시장의 성장을 견인할 것으로 예상됩니다. 신경질환에는 뇌, 척수, 신경을 포함한 신경계에 영향을 미치는 질환이 포함됩니다. 이러한 질환은 유전적 소인, 감염, 외상, 독소, 자가면역반응, 퇴행 등에 의해 발생합니다. 신경유전학적 검사는 신경질환의 진단, 치료, 관리를 강화하는 데 중요한 역할을 합니다. 유전적 위험 요인에 대한 개인화된 인사이트를 제공하고, 치료 방침을 결정하고, 환자와 가족이 정보에 입각한 의료 선택을 할 수 있도록함으로써 환자 치료와 결과를 개선할 수 있습니다. 예를 들어, 2022년 4월 European Brain Council이 보고한 바에 따르면, 전 세계적으로 600개 이상의 신경질환과 300개에 가까운 정신질환으로 수백만 명이 고통받고 있으며, 그 중에는 6,500만 명의 간질 환자가 포함되어 있습니다. 유럽에서는 1,050만 명이 치매를 앓고 있으며, 2050년에는 1,870만 명으로 증가할 것으로 예측됩니다. 따라서 신경질환의 유병률 증가는 신경유전학적 검사 시장의 성장을 촉진할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신경유전학적 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 신경유전학적 검사 시장 : 성장률 분석
세계의 신경유전학적 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 신경유전학적 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 신경유전학적 검사 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 신경유전학적 검사 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
마이크로어레이 분석
전장 엑솜 시퀀싱(WES)
멀티플렉스 결찰 의존 프로브 증폭(MLPA)
중합효소 연쇄 반응(PCR) 검사
기타 유형
세계의 신경유전학적 검사 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
희소 유전성 질환
암
낭포성섬유증
겸상 적혈구 빈혈
듀셴형 근이영양증
지중해빈혈
헌팅턴병
취약 X 증후군
기타 질병
세계의 신경유전학적 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
조사기관
진단 연구소
세계의 신경유전학적 검사 시장 : 하위 세분화 마이크로어레이 분석(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
CGH(Comparative Genomic Hybridization) 마이크로어레이
단일염기다형(SNP) 마이크로어레이
유전자 발현 마이크로어레이
세계의 신경유전학적 검사 시장 : 하위 세분화 전장 엑솜 시퀀싱(WES), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
표적 엑솜 시퀀싱
임상 엑솜 시퀀싱
연구 등급 엑솜 시퀀싱
세계의 신경유전학적 검사 시장 : 하위 세분화 멀티플렉스 결찰 의존 프로브 증폭(MLPA), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
복제수 변이를 위한 MLPA
메틸화 분석을 위한 MLPA
특정 질환 검출을 위한 MLPA
세계의 신경유전학적 검사 시장 : 하위 세분화 중합효소 연쇄 반응(PCR) 검사 종류, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정량 PCR(qPCR)
역전사 PCR(RT-PCR)
디지털 PCR(dPCR)
세계의 신경유전학적 검사 시장 : 하위 세분화 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀀싱(NGS)
서던 블롯팅
FISH(Fluorescent In Situ Hybridization)
생어 시퀀싱
제7장 지역별·국가별 분석
세계의 신경유전학적 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 신경유전학적 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
신경유전학적 검사 시장 : 경쟁 구도
신경유전학적 검사 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Eurofins Scientific Inc.
Agilent Technologies Inc.
PerkinElmer Inc.
Illumina Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Exact Sciences Corporation
Myriad Genetics Inc.
BioReference Laboratories Inc.
Connecticut Children's
Invitae Corp.
Ambry Genetics Corporation
Fulgent Genetics Inc.
Blueprint Genetics Inc.
GeneDx LLC
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
신경유전학적 검사 시장 2029 : 새로운 기회를 제공하는 국가
신경유전학적 검사 시장 2029 : 새로운 기회를 제공하는 부문
신경유전학적 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Neurogenetic testing is a form of genetic testing that focuses on identifying genetic variations linked to neurological disorders or conditions impacting the nervous system. It aids in diagnosis, prediction, and management of neurological disorders, supports research, and helps develop personalized treatment strategies in neurology and genetics.
The main types of neurogenetic testing in the market include microarray analysis, whole-exome sequencing (WES), multiplex ligation-dependent probe amplification (MLPA), polymerase chain reaction (PCR) tests, and others. Microarray analysis is a technique in neurogenetic testing that simultaneously assesses the expression levels of thousands of genes. These tests are used for various diseases such as rare genetic disorders, cancer, cystic fibrosis, sickle cell anemia, Duchenne muscular dystrophy, thalassemia, Huntington's disease, fragile X syndrome, and others. They are utilized by hospitals, specialty clinics, research institutes, and diagnostics laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The neurogenetic testing market research report is one of a series of new reports from The Business Research Company that provides neurogenetic testing market statistics, including neurogenetic testing industry global market size, regional shares, competitors with a neurogenetic testing market share, detailed neurogenetic testing market segments, market trends, and opportunities, and any further data you may need to thrive in the neurogenetic testing industry. This neurogenetic testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The neurogenetic testing market size has grown rapidly in recent years. It will grow from $0.61 billion in 2024 to $0.7 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increased prevalence of neurological disease cases, increase research in life science domain, increasing prevalence of parkinson's disease, increased cases of cancer, and rising awareness among healthcare professionals.
The neurogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to expanding applications in personalized medicine, rise in chronic diseases, increased number of hospitals, increased number of diagnostic laboratories and growing demand for early disease detection. Major trends in the forecast period include technological advancement, greater adoption of non-invasive testing methods, new product development, strategic collaborations, and the emergence of novel biomarkers for neurological conditions.
The forecast of 12.7% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. precision neurology by increasing costs for whole-exome sequencing kits and Artificial intelligence-based variant interpretation software imported from South Korea and Finland, potentially delaying diagnoses and raising neurogenetics laboratory operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increase in neurological disorders is expected to drive the growth of the neurogenetic testing market. Neurological disorders encompass conditions affecting the nervous system, including the brain, spinal cord, and nerves. These disorders can arise from genetic predisposition, infections, trauma, toxins, autoimmune responses, or degeneration. Neurogenetic testing plays a crucial role in enhancing the diagnosis, treatment, and management of neurological disorders. It provides personalized insights into genetic risk factors, guides treatment decisions, and empowers patients and families to make informed healthcare choices, thereby improving patient care and outcomes. For example, as reported by the European Brain Council in April 2022, millions globally suffer from over 600 neurological diseases and nearly 300 psychiatric conditions, including 65 million with epilepsy. In Europe, 10.5 million people have dementia, with projections indicating a rise to 18.7 million by 2050. Hence, the increasing prevalence of neurological disorders is expected to fuel the growth of the neurogenetic testing market.
The rising prevalence of cancer is also expected to boost the neurogenetic testing market. Cancer, characterized by uncontrolled cell division and tissue destruction, is on the rise due to factors such as the obesity epidemic, inherited genetic abnormalities, and viral infections such as hepatitis B and C, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Neurogenetic testing is crucial for cancer management as it aids in selecting the most effective treatment, assessing prognoses, identifying high-risk patients, and providing personalized care based on individual genetic profiles and family history. For instance, the American Society of Clinical Oncology reported in May 2024 that an estimated 20 million new cancer cases were identified in 2022, with projections of 35 million new cases globally by 2050, leading to 9.7 million deaths from the disease. Consequently, the increasing prevalence of cancer is propelling the growth of the neurogenetic testing market.
Major companies are focusing on developing innovative products such as whole-genome sequencing to improve genetic analysis accuracy and scope. Whole-genome sequencing (WGS) is a comprehensive genetic testing method that involves determining an individual's entire genome DNA sequence. For instance, Nucleus Genomics, a US-based company specializing in genetic analysis, launched a DNA analysis product in March 2024. This platform provides people with a deeper understanding of their genetic predispositions, enabling informed decisions about health and well-being. Nucleus Genomics aims to redefine genetic testing by offering cutting-edge technology and expert genetic counseling services, making whole-genome sequencing accessible and revolutionizing genomic medicine.
North America was the largest region in the neurogenetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the neurogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neurogenetic testing market includes revenues earned by entities by providing services such as diagnostic testing, predictive testing, carrier screening, and prenatal testing and related products such as genetic testing kits, DNA sequencing platforms, and bioinformatics software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurogenetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neurogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neurogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurogenetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation; MLPA For Methylation Analysis; MLPA For Specific Disease Detection
4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR); Reverse Transcription PCR (RT-PCR); Digital PCR (dPCR)
5) By Other Types: Next-Generation Sequencing (NGS); Southern Blotting; Fluorescence In Situ Hybridization (FISH); Sanger Sequencing
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neurogenetic Testing Market Characteristics
3. Neurogenetic Testing Market Trends And Strategies
4. Neurogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Neurogenetic Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Neurogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neurogenetic Testing Market Growth Rate Analysis
5.4. Global Neurogenetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neurogenetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neurogenetic Testing Total Addressable Market (TAM)
6. Neurogenetic Testing Market Segmentation
6.1. Global Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.2. Global Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rare Genetic Disorder
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington's Disease
Fragile X Syndrome
Other Diseases
6.3. Global Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
6.4. Global Neurogenetic Testing Market, Sub-Segmentation Of Microarray Analysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.5. Global Neurogenetic Testing Market, Sub-Segmentation Of Whole-Exome Sequencing (WES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Exome Sequencing
Clinical Exome Sequencing
Research-Grade Exome Sequencing
6.6. Global Neurogenetic Testing Market, Sub-Segmentation Of Multiplex Ligation Dependent Probe Amplification (MLPA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
MLPA For Copy Number Variation
MLPA For Methylation Analysis
MLPA For Specific Disease Detection
6.7. Global Neurogenetic Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative PCR (qPCR)
Reverse Transcription PCR (RT-PCR)
Digital PCR (dPCR)
6.8. Global Neurogenetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Southern Blotting
Fluorescence In Situ Hybridization (FISH)
Sanger Sequencing
7. Neurogenetic Testing Market Regional And Country Analysis
7.1. Global Neurogenetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neurogenetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
